Asia Pacific Pulmonary Arterial Hypertension Market Outlook

asia pacific is an emerging pulmonary arterial hypertension (pah) market, projected to register substantial growth over the forecast period of 2018 to 2032. this is primarily due to the increasing prevalence of pulmonary arterial hypertension among the asia pacific countries, rising awareness regarding the disease, and increasing adoption of various medicines for the treatment of the disease. pah is a rare and severe disease, caused by high pressure in the pulmonary artery and leads to stiffening of valves in the heart. common symptoms of pah includes, chest pain, fatigue, palpitations, balance issues, difficulty in breathing, and changes in vision. notably, various genetic mutations are found to be associated with pulmonary arterial hypertension. the increasing prevalence of the disease in the asia pacific region is mainly due to lifestyle changes, smoking, pulmonary diseases, and hypoxic exposures. with rising life expectancy of the residents in asia pacific, the prevalence of pah is also projected to surge over the forecast period. concerning the diagnosis of pulmonary arterial hypertension, it is done through right heart catheterization and echocardiography. however, the diagnosis of pah is difficult due to its rare nature and lack of awareness. as a result, there is a need for government-mandated initiatives and collaborations of the public and private healthcare sectors to create awareness among themedical fraternity regarding the symptoms and diagnosis of the disease. in terms of therapy, the deployment of various therapeutic options such as endothelin receptor antagonists and prostacyclin analogues have made the management of pulmonary hypertension feasible. this increases the demand for pah therapeutic options, and thus, is expected to be a major factor for the rising growth of the asia pacific pulmonary arterial hypertension market. pharmaceutical companies are also focusing on conducting clinical trials to gain a better understanding of ongoing sales opportunities in the asia pacific pulmonary hypertension market. as a result, the asia pacific pulmonary hypertension market is expected to show significant growth over the forecast period.